sutent

SUTENT may not work the same in every person .

但索坦对每个人的作用不一样。

SUTENT may help slow down this process .

索坦可以帮助延缓这个过程。

SUTENT may not be appropriate for all GIST patients and has not been studied in children .

索坦并不适合所有的胃肠道间质瘤的患者，且并未对儿童患者进行研究。

For many patients , SUTENT may slow or stop the growth of cancer and may help to shrink tumors .

对很多患者，索坦可以延缓或阻止肿瘤的进展，并帮助消退肿瘤。

SUTENT is available by prescription only .

索坦只能通过医生处方获得。

Because these proteins are involved in both tumor proliferation and angiogenesis , Sutent has both anti-tumor as well as anti-angiogenic properties .

这些蛋白质存在于肿瘤的增殖和血管形成过程中，因而Sutent兼有抗肿瘤和抗血管发生的特性。

Sutent 's sales can quadruple to $ 2 billion by2016 if proven to prolong life for breast cancer patients , an analyst said .

舒尼替尼如果能延长乳腺癌病人的生命，到2016年它的销售额将增加4倍到20亿美元。

Pfizer 's Sutent , cleared last year for late-stage kidney cancer , showed'promising activity'against malignant breast cells , researchers said at a medical meeting Dec.16 .

辉瑞公司一直用于治疗晚期肾癌的舒尼替尼被发现在抗恶性乳腺细胞方面具有“显著活性”。

The drug powerhouse is testing two com ­ pounds that could benefit specific genotypes : Sutent for gastrointestinal tumors and kidney cancer , and CP-751,871 for bone marrow cancer .

该公司的药物实验室正在测试两种针对特殊基因的化合物的疗效。一种叫Sutent，针对胃和肠道肿瘤和肾癌，另一种叫CP-751871，专门针对骨膜癌。

Sutent , approved for stomach and kidney tumors in Jan.2006 , attacks tumors by depriving them of their blood supply , in a process known as anti-angiogenesis .

2006年1月舒尼替尼被批准用于胃癌和肾癌，通过阻断血液供给杀死癌细胞（著名的抑制血管新生法）。